Relation of the prothrombotic state to increasing age (from the Framingham Offspring Study)

Geoffrey H Tofler1, Joseph Massaro, Daniel Levy

  • 1Royal North Shore Hospital, Sydney, Australia. gtofler@nsccahs.health.nsw.gov.au

Insights

Advancing age increases thrombotic potential, raising cardiovascular disease risk. This study found older adults have higher levels of clotting factors, indicating a prothrombotic state linked to endothelial dysfunction.

Area of Science:

  • Cardiovascular Medicine
  • Gerontology
  • Hematology

Background:

  • Increased life expectancy leads to a growing elderly population.
  • Age is a significant cardiovascular disease risk factor, but underlying mechanisms are unclear.
  • Thrombosis is crucial in cardiovascular events, suggesting age-related prothrombotic imbalance contributes to risk.

Purpose of the Study:

  • To investigate the relationship between age and thrombotic potential.
  • To analyze hemostatic factors in relation to aging in a healthy cohort.

Main Methods:

  • Examined 3,230 participants (Framingham Offspring Cohort, cycle 5) without cardiovascular disease.
  • Measured hemostatic factors (fibrinogen, von Willebrand factor, PAI-1, t-PA) across age decades.
  • Utilized multivariate analysis to adjust for confounding factors.

Main Results:

  • Advancing age correlated with increased fibrinogen and von Willebrand factor levels.
  • Older age groups showed impaired fibrinolytic potential (higher PAI-1, t-PA).
  • Significant associations persisted after multivariate adjustment, with higher fibrinogen in older men and women.

Conclusions:

  • Aging is associated with a prothrombotic state due to elevated hemostatic factors.
  • These age-related changes may indicate endothelial injury.
  • Interventions to reduce thrombotic potential may benefit the elderly.

Related Concept Videos

Bone Disorders01:29

Bone Disorders

Aging and its effect on bone remodeling is the most common cause of bone disorders. In young and healthy people, bone deposition and resorption happen at an equal rate to maintain optimal bone health.
Bone deposition is also affected by the levels of sex hormones like estrogen and testosterone that promote osteoblast activity and bone matrix synthesis. When the level of these hormones decreases due to aging, it causes a reduction in bone deposition. As a result, bone resorption by osteoclasts...
Drug Dosing: Geriatric Patients01:15

Drug Dosing: Geriatric Patients

Elderly individuals encompass a diverse population with varying degrees of age-related physiological changes. Defining the elderly presents challenges, as the geriatric population is often arbitrarily categorized as individuals older than 65. However, many individuals in this group lead active and healthy lives, with an increasing number surpassing 85 years and falling into the older elderly category. Physiological changes associated with aging impact performance capacity and homeostatic...
Pharmacokinetics in Geriatric Patients: Effect of Age on Drug Distribution01:00

Pharmacokinetics in Geriatric Patients: Effect of Age on Drug Distribution

Drug distribution in the human body is influenced by several factors, including plasma protein concentration, body composition, blood flow, tissue-protein concentration, and tissue fluid pH. Among these, changes in plasma protein concentration and body composition due to aging significantly affect how drugs are distributed within the body. Specifically, aging is associated with a decrease in albumin levels by about 10% and an increase in α1-acid glycoprotein levels. These alterations are not...
Pharmacokinetics in Geriatric Patients: Effect of Age on Drug Metabolism01:18

Pharmacokinetics in Geriatric Patients: Effect of Age on Drug Metabolism

Geriatric patients show significant variation in how their bodies process medications, which can change how effective and safe treatments are. The liver is the primary organ where drug metabolism occurs, involving two main types of chemical reactions: phase I and II. Phase I metabolism is driven by the cytochrome P450 enzyme system, which includes key types such as CYP3A, CYP2D6, and CYP2C9. Research indicates that while aging doesn't notably alter the levels or activity of these enzymes, it...
Pharmacodynamics in Geriatric Patients: Effects of Age01:27

Pharmacodynamics in Geriatric Patients: Effects of Age

Age-related pharmacokinetic changes are extensively documented, but understanding age-related pharmacodynamic alterations is relatively limited. This knowledge gap can be partly attributed to the complexity of developing appropriate measures of drug responses compared to bioanalytical methods for determining drug concentrations.Most information regarding age-related differences in human pharmacodynamics originates from cross-sectional studies. However, these studies assume that observed mean...
Aging01:26

Aging

Aging is a complex biological phenomenon influenced by various processes that affect cellular and systemic functions. Several prominent theories attempt to explain its mechanisms, highlighting cellular limitations, oxidative damage, and hormonal changes as central factors in aging.
Cellular Clock Theory
The cellular clock theory posits that the human lifespan is closely tied to the finite capacity of cells to divide, a phenomenon governed by telomeres, which are protective caps at the ends of...